Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Acquired by Congress Wealth Management LLC DE

Congress Wealth Management LLC DE increased its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 6.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 147,715 shares of the company’s stock after acquiring an additional 8,505 shares during the period. Congress Wealth Management LLC DE owned approximately 0.30% of Prestige Consumer Healthcare worth $11,535,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Kestra Investment Management LLC acquired a new position in shares of Prestige Consumer Healthcare in the 4th quarter worth approximately $27,000. GAMMA Investing LLC grew its position in Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company’s stock worth $108,000 after buying an additional 220 shares during the last quarter. KBC Group NV increased its holdings in shares of Prestige Consumer Healthcare by 28.3% in the fourth quarter. KBC Group NV now owns 2,048 shares of the company’s stock valued at $160,000 after buying an additional 452 shares in the last quarter. Blue Trust Inc. lifted its position in shares of Prestige Consumer Healthcare by 24.8% during the 4th quarter. Blue Trust Inc. now owns 2,190 shares of the company’s stock valued at $158,000 after acquiring an additional 435 shares during the last quarter. Finally, Longboard Asset Management LP bought a new stake in shares of Prestige Consumer Healthcare during the 4th quarter worth $201,000. 99.95% of the stock is currently owned by institutional investors.

Insider Activity at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the firm’s stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. This trade represents a 8.91 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on PBH. Oppenheimer boosted their target price on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research report on Thursday, February 13th. Sidoti lowered shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. Canaccord Genuity Group raised their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the stock a “buy” rating in a report on Friday, February 7th. StockNews.com upgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Tuesday, March 18th. Finally, Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, Prestige Consumer Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

NYSE PBH opened at $85.46 on Tuesday. The company has a 50 day simple moving average of $82.67 and a 200-day simple moving average of $78.72. Prestige Consumer Healthcare Inc. has a 52-week low of $62.35 and a 52-week high of $90.04. The firm has a market capitalization of $4.23 billion, a price-to-earnings ratio of 20.01, a price-to-earnings-growth ratio of 2.69 and a beta of 0.46. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20.

Prestige Consumer Healthcare (NYSE:PBH) last released its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. Equities research analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.